Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank57
5Y CAGR-4.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

5Y CAGR
-4.6%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$37.32M-71.7%
2024$131.90M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$47.23M-16.9%
2019$56.84M-10.9%
2018$63.75M-3.7%
2017$66.20M+53.8%
2016$43.04M-